Balrampur Chini Mills Eyes Major Growth with ₹4,500cr Share Sale and Enhanced PLA Project Capex

Balrampur Chini Mills' board has approved a significant ₹4,500 crore preferential issue, alongside a plan to raise up to ₹200 crore through Non-Convertible Debentures (NCDs). The company also revised the capital expenditure for its Poly Lactic Acid (PLA) project upwards to ₹3,080 crore. Additionally, a new Gypsum Processing Plant was sanctioned for Kumbhi, Uttar Pradesh, with an estimated cost of ₹160 crore. The preferential issue was approved at ₹483 per share.

Strategic Expansion and Diversification

These strategic moves underscore Balrampur Chini's commitment to expanding its business beyond traditional sugar and ethanol production. The increased investment in the PLA project positions the company to enter the growing bioplastics market with what is planned to be India's first industrial-scale bio-polymer plant. The new gypsum plant aims to capitalize on by-products from the PLA manufacturing process, adding another revenue stream.

Company Background and Diversification Drive

A long-standing leader in the sugar industry, Balrampur Chini has been progressively diversifying into ethanol and power generation. This latest development marks a substantial step into advanced materials with its PLA venture. The PLA project's investment has seen prior revisions, initially slated for ₹2,000 crore and previously adjusted to ₹2,850 crore before the current increase.

Key Developments and Implications

The approved preferential issue will strengthen the company's financial foundation for its large-scale projects. Shareholders will have an opportunity to participate in this equity raise. The higher capital expenditure on the PLA project signals a deeper commitment to sustainable materials. The NCD issuance further bolsters the company's debt-raising capabilities. The gypsum plant is projected to be operational by December 2027, with a capacity of 76 lakh gypsum boards annually.

Potential Risks and Challenges

The upward revision of the PLA project's capital expenditure, attributed to rising construction material costs and persistent global supply chain disruptions, highlights the potential for further cost increases or project delays. Executing and scaling this novel bioplastics plant, a significant new venture for the company, also presents inherent operational challenges.

Competitive Landscape

Balrampur Chini's peers, such as Dhampur Sugar Mills and DCM Shriram, are also engaged in diversification. Dhampur Sugar Mills is expanding into chemicals and exploring compressed bio-gas, while DCM Shriram has investments in renewable energy and a broader portfolio. Balrampur Chini's focused entry into the bioplastics segment offers a unique strategic position relative to these competitors.

What to Watch For

Investors will be monitoring the Extra-Ordinary General Meeting (EGM) on May 20, 2026, for shareholder approval of the preferential issue. Key details regarding the terms and conditions of the proposed NCD issuance are also anticipated. Progress on the construction and commissioning timeline for the new gypsum plant will be important. Furthermore, the company's ability to manage the deployment of funds, control costs amid market pressures, and successfully scale its new bioplastics business will be crucial indicators.